Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 644 of 1,261
  1. US 9597290

    Particle functionalization

    Regents of the University of Minnesota · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  2. US 9593082

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  3. US 9593333

    Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations

    Ionis Pharmaceuticals, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  4. US 9593151

    Use of fusion protein

    East China University of Science and Technology · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  5. US 9593136

    Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  6. US 9593131

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  7. US 9593066

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  8. US 9593110

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  9. US 9593108

    Compounds and methods for antiviral treatment

    PTC THERAPEUTICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  10. US 9593077

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  11. US 9593080

    Triazabutadienes as cleavable cross-linkers

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  12. US 9592290

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  13. US 9592271

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  14. US 9592291

    Methods for iontophoretically treating nausea and migraine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  15. US 9592309

    Positron emission tomography probe to monitor selected sugar metabolism in vivo

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  16. US 9592238

    Anti-ceramide monoclonal antibody 2A2

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  17. US 9592232

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  18. US 9592221

    Antibacterial agents: aryl myxopyronin derivatives

    Provid Pharmaceuticals Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  19. US 9592255

    Scaffold-free three dimensional nerve fibroblast constructs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  20. US 9592200

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  21. US 9592196

    Methods and compositions for applying pharmacologic agents to the ear

    Regents of the University of Minnesota · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  22. US 9592180

    Method and device for treating allergic reactions and difficult-to-manage respiratory diseases

    Pharmaceutical Design, LLC · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  23. US 9592256

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  24. US 9593069

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.